A detailed history of Cardinal Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Cardinal Capital Management holds 28,702 shares of LLY stock, worth $22.8 Million. This represents 4.03% of its overall portfolio holdings.

Number of Shares
28,702
Previous 28,949 0.85%
Holding current value
$22.8 Million
Previous $26.2 Million 2.98%
% of portfolio
4.03%
Previous 4.5%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$772.14 - $960.02 $190,718 - $237,124
-247 Reduced 0.85%
28,702 $25.4 Million
Q2 2024

Jul 12, 2024

SELL
$724.87 - $909.04 $3.58 Million - $4.49 Million
-4,941 Reduced 14.58%
28,949 $26.2 Million
Q1 2024

Jul 12, 2024

SELL
$592.2 - $792.28 $320,972 - $429,415
-542 Reduced 1.57%
33,890 $26.4 Million
Q1 2024

Apr 15, 2024

SELL
$592.2 - $792.28 $320,972 - $429,415
-542 Reduced 1.57%
33,890 $26.4 Million
Q4 2023

Jul 12, 2024

SELL
$525.19 - $619.13 $649,134 - $765,244
-1,236 Reduced 3.47%
34,432 $20.1 Million
Q4 2023

Jan 26, 2024

SELL
$525.19 - $619.13 $649,134 - $765,244
-1,236 Reduced 3.47%
34,432 $20.1 Million
Q3 2023

Jul 12, 2024

SELL
$434.7 - $599.3 $244,736 - $337,405
-563 Reduced 1.55%
35,668 $19.2 Million
Q3 2023

Oct 16, 2023

SELL
$434.7 - $599.3 $244,736 - $337,405
-563 Reduced 1.55%
35,668 $19.2 Million
Q2 2023

Jul 12, 2024

BUY
$350.74 - $468.98 $821,082 - $1.1 Million
2,341 Added 6.91%
36,231 $17 Million
Q2 2023

Jul 12, 2023

SELL
$350.74 - $468.98 $374,239 - $500,401
-1,067 Reduced 2.86%
36,231 $17 Million
Q1 2023

Apr 18, 2023

SELL
$310.63 - $364.82 $410,963 - $482,656
-1,323 Reduced 3.43%
37,298 $12.8 Million
Q4 2022

Jan 20, 2023

SELL
$321.55 - $374.67 $298,076 - $347,319
-927 Reduced 2.34%
38,621 $0
Q3 2022

Oct 21, 2022

SELL
$296.48 - $337.87 $101,989 - $116,227
-344 Reduced 0.86%
39,548 $12.8 Million
Q2 2022

Aug 04, 2022

SELL
$278.73 - $327.27 $104,523 - $122,726
-375 Reduced 0.93%
39,892 $12.9 Million
Q1 2022

Apr 21, 2022

BUY
$234.69 - $291.66 $52,335 - $65,040
223 Added 0.56%
40,267 $11.5 Million
Q4 2021

Jan 18, 2022

SELL
$224.85 - $279.04 $129,738 - $161,006
-577 Reduced 1.42%
40,044 $11.1 Million
Q3 2021

Oct 21, 2021

SELL
$221.6 - $272.71 $366,969 - $451,607
-1,656 Reduced 3.92%
40,621 $9.39 Million
Q2 2021

Jul 14, 2021

SELL
$180.55 - $233.54 $8,485 - $10,976
-47 Reduced 0.11%
42,277 $9.7 Million
Q1 2021

Apr 19, 2021

SELL
$164.32 - $212.72 $53,239 - $68,921
-324 Reduced 0.76%
42,324 $7.91 Million
Q4 2020

Feb 01, 2021

BUY
$130.46 - $172.63 $7,436 - $9,839
57 Added 0.13%
42,648 $7.2 Million
Q3 2020

Oct 16, 2020

SELL
$146.22 - $169.13 $150,021 - $173,527
-1,026 Reduced 2.35%
42,591 $6.3 Million
Q2 2020

Jul 16, 2020

SELL
$136.42 - $164.18 $74,621 - $89,806
-547 Reduced 1.24%
43,617 $7.16 Million
Q1 2020

Apr 20, 2020

SELL
$119.05 - $147.35 $225,242 - $278,786
-1,892 Reduced 4.11%
44,164 $6.13 Million
Q4 2019

Jan 21, 2020

SELL
$106.92 - $132.43 $79,334 - $98,263
-742 Reduced 1.59%
46,056 $6.05 Million
Q3 2019

Oct 18, 2019

SELL
$106.79 - $116.16 $12,921 - $14,055
-121 Reduced 0.26%
46,798 $5.23 Million
Q2 2019

Jul 08, 2019

SELL
$110.79 - $129.32 $84,089 - $98,153
-759 Reduced 1.59%
46,919 $5.2 Million
Q1 2019

Apr 11, 2019

SELL
$111.31 - $131.02 $42,854 - $50,442
-385 Reduced 0.8%
47,678 $6.19 Million
Q4 2018

Jan 15, 2019

BUY
$105.9 - $118.64 $25,733 - $28,829
243 Added 0.51%
48,063 $5.56 Million
Q3 2018

Oct 25, 2018

SELL
$85.86 - $107.31 $35,030 - $43,782
-408 Reduced 0.85%
47,820 $5.13 Million
Q2 2018

Jul 25, 2018

SELL
$75.7 - $86.88 $8,629 - $9,904
-114 Reduced 0.24%
48,228 $4.12 Million
Q1 2018

Apr 25, 2018

SELL
$74.21 - $87.6 $20,481 - $24,177
-276 Reduced 0.57%
48,342 $3.74 Million
Q4 2017

Feb 01, 2018

SELL
$81.94 - $87.89 $99,475 - $106,698
-1,214 Reduced 2.44%
48,618 $4.11 Million
Q3 2017

Oct 24, 2017

BUY
$77.07 - $85.54 $3.84 Million - $4.26 Million
49,832
49,832 $4.26 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cardinal Capital Management Portfolio

Follow Cardinal Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Cardinal Capital Management with notifications on news.